Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;8(3):273-83.
doi: 10.1111/eva.12196. Epub 2014 Aug 27.

The fitness costs of antibiotic resistance mutations

Affiliations
Review

The fitness costs of antibiotic resistance mutations

Anita H Melnyk et al. Evol Appl. 2015 Mar.

Abstract

Antibiotic resistance is increasing in pathogenic microbial populations and is thus a major threat to public health. The fate of a resistance mutation in pathogen populations is determined in part by its fitness. Mutations that suffer little or no fitness cost are more likely to persist in the absence of antibiotic treatment. In this review, we performed a meta-analysis to investigate the fitness costs associated with single mutational events that confer resistance. Generally, these mutations were costly, although several drug classes and species of bacteria on average did not show a cost. Further investigations into the rate and fitness values of compensatory mutations that alleviate the costs of resistance will help us to better understand both the emergence and management of antibiotic resistance in clinical settings.

Keywords: adaptation; antibiotic resistance; fitness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimation of selection coefficients using the Lenski and Dykhuisen estimators. Competition experiments were simulated for two strains, with the wild-type strain doubling in each time unit, and the growth rate of the focal strain reduced compared to wild type by 0 to 0.25. Competition lasted six generations, starting with a 50:50 ratio of the two strains and an initial population size of 1 million. Each data point represents the mean values of s for 100 simulations. For each replicate, an average of 100 individuals were sampled and used to calculate sl (y-axis) and sd (x-axis). The dashed line represents a 1:1 relationship, and the solid line gives the linear regression of sl on sd.
Figure 2
Figure 2
The mean relative fitness and 95% confidence intervals of antibiotic resistance mutations associated with a given antibiotic, grouped by class of antibiotic (from top to bottom alpha-pyrone, aminoglycoside, coumarin, dihydrofolate reductase inhibitor, fusidane, macrolide, quinolone and rifamycin). A fitness value of <1 indicates a fitness cost in the absence of the antibiotic.
Figure 3
Figure 3
The mean relative fitness and 95% confidence intervals of antibiotic resistance mutations associated with a given species. A fitness value of <1 indicates a fitness cost in the absence of the antibiotic.
Figure 4
Figure 4
Species–antibiotic comparisons of the mean relative fitness of resistance mutations in the absence of the antibiotic. Numbers indicate antibiotic class: 1 – alpha-pyrone, 2 – aminoglycoside, 3 – coumarin, 4 – dihydrofolate reductase inhibitor (DHRI), 5 – fusidane, 6 – macrolide, 7 – quinolone and 8 – rifamycin.
Figure 5
Figure 5
The level of resistance conferred by a mutation is negatively correlated with its’ fitness in the absence of the antibiotic (r2 = 0.228). Different symbols are associated with different classes of antibiotic.

References

    1. Andersson DI. Persistence of antibiotic resistant bacteria. Current Opinion in Microbiology. 2003;6:452–456. - PubMed
    1. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Current Opinion in Microbiology. 2006;9:461–465. - PubMed
    1. Andersson DI. Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Reviews Microbiology. 2010;8:260–271. - PubMed
    1. Arason V, Gunnlaugsson A, Sigurdsson J, Erlendsdottir H, Gudmundsson S. Kristinsson KG. Clonal spread of resistant Pneumococci despite diminished antimicrobial use. Microbial Drug Resistance. 2002;8:187–192. - PubMed
    1. Austin DJ, Kristinsson KG. Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences. 1999;96:1152–1156. - PMC - PubMed